Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H6N2OS |
Molecular Weight | 142.179 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC(=O)NC(=S)N1
InChI
InChIKey=HWGBHCRJGXAGEU-UHFFFAOYSA-N
InChI=1S/C5H6N2OS/c1-3-2-4(8)7-5(9)6-3/h2H,1H3,(H2,6,7,8,9)
Molecular Formula | C5H6N2OS |
Molecular Weight | 142.179 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Methylthiouracil is an orally active thyroid enzyme activity inhibitor. Methylthiouracil was introduced in the mid-1940s for the treatment of hyperthyroidism. Methylthiouracil is no longer in clinical use in most countries, although it may be used to a limited degree in some eastern European countries. Methylthiouracil possess anti-inflammatory effects in vitro and in vivo and was found effective in a murine model of sepsis.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P49895|||Q6Q4C6 Gene ID: 1733.0 Gene Symbol: DIO1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/23883148 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseFor the treatment of low-grade thyrotoxicosis, methylthiouracil is administered at 0.05 g/day in combination with low doses of iodine. For the treatment of medium and high-grade thyrotoxicosis, methylthiouracil is administered at 0.05-0.25 g 1-3 times/day for 15-25 days. |
|||
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26239884 |
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Aplastic anaemia after propylthiouracil. | 1968 Jun 22 |
|
Structure-activity relationship of ligands of uracil phosphoribosyltransferase from Toxoplasma gondii. | 1994 Aug 17 |
|
Influence of thioketo substitution on the properties of uracil and its noncovalent interactions with alkali metal ions: threshold collision-induced dissociation and theoretical studies. | 2006 Feb 2 |
|
Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro. | 2011 Jan 26 |
|
Antithyroid drugs and their analogues: synthesis, structure, and mechanism of action. | 2013 Nov 19 |
|
Anti-inflammatory effects of methylthiouracil in vitro and in vivo. | 2015 Nov 1 |
|
Methylthiouracil, a new treatment option for sepsis. | 2017 Jan |
Patents
Sample Use Guides
For the treatment of low-grade thyrotoxicosis, methylthiouracil is administered at 0.05 g/day in combination with low doses of iodine. For the treatment of medium and high-grade thyrotoxicosis, methylthiouracil is administered at 0.05-0.25 g 1-3 times/day for 15-25 days.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13264643
The effect of methylthiouracil on the conversion of thyroxine to triiodothyronine in kidney tissue slices was investigated using a transformation of chromatically pure l-thyroxine labeled with 131I. Methylthiouracil 15 ug dissolved in an alkaline medium was added to the kidney preparations before incubation. The butanol extracts were analyzed by paper chromatography and radioactivity was registered on the chromatogram.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:13:20 GMT 2023
by
admin
on
Fri Dec 15 15:13:20 GMT 2023
|
Record UNII |
QW24888U5F
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
IARC | Methylthiouracil | ||
|
NCI_THESAURUS |
C885
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
||
|
WHO-ATC |
H03BA01
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
||
|
WHO-VATC |
QH03BA01
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
QW24888U5F
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
100000080909
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
56-04-2
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
193526
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
D008779
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
200-252-3
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
C81590
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
1773
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
3366
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
METHYLTHIOURACIL
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
DB13644
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
m7471
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | Merck Index | ||
|
4150
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
DTXSID2020890
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
CHEMBL1330588
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
667493
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
SUB08878MIG
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |